Privacy Policy
Signals Blog

Contributors

Categories

Good riddance to 2020!

I realize I can only speak for myself, but I suspect I’m not alone in moving into 2021 feeling hopeful and optimistic that it has got to be better than the year we just went through. With a new president in the White House and vaccinations being administered around the world, maybe we can now stop holding our collective breaths.

While we can finally put this difficult year behind us, one reason for looking back is to catch up on the most popular blogs of the last 12 months that you may have missed (“popular” based on how many readers each one had). So beginning with the most read blog, if any of these titles are new to you, please have a read so we can close the book – er blog – on 2020.

Wishing you and the bloggers all the best in 2021. Happy New Year and happy reading.

  1. Opportunities for professional growth in your science career in 2020
  2. Communicating new science in a crisis
  3. Could stem cells be enlisted to battle COVID-19?
  4. Right Turn: Lots to ponder in genetics documentary
  5. Stem cell training – Supplementary resources
  6. Canadian immunotherapy holds promise for patients with brain cancer
  7. Right Turn: The need for diversity in STEM
  8. Blog Carnival: Cell and gene therapy industry to emerge stronger post-COVID-19
  9. Covid-19 infects lab-grown mini-organs: Here’s how the new organoid technology is contributing to COVID-19 research
  10. Blood stem cell gene therapy – the comeback kid of experimental medicine

 

via GIPHY

The following two tabs change content below.
Avatar photo

Stacey Johnson

Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.